Kangji Medical

Company Deals

Kangji Medical Proposes Privatization, Aiming to Delist from Hong Kong Stock Exchange

Fineline Cube Aug 13, 2025

Kangji Medical Holdings Limited (HKG: 9997) has submitted a proposal to its shareholders regarding a...

Company Drug

Biogen’s High‑Dose SPINRAZA Wins EU Approval for 5q SMA After Japan Nod

Company Deals

InventisBio Files for Hong Kong IPO, Betting on Oncology and Metabolic Pipeline

Company Deals

Boston Scientific to Acquire Penumbra in $14.5 Billion Deal, Bolsters Thrombectomy Leadership

Company Drug

Gan & Lee’s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi’s Dominance